Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

By B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin. New England Journal of Medicine, 2000

1,321 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/cd610720a536a09f48b956a0a52338db8a47e59e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. P. Ridker
2. JoAnn E. Manson
3. N. Rifai
4. Hani Jneid
5. E. Braunwald
6. Peter Libby
7. B. K. Pedersen
8. L. Melvin

In Oncology

1. P. Ridker
2. N. Rifai
3. B. K. Pedersen
4. Peter Libby
5. Jongsoon Lee
6. F. B. Hu

In Pulmonary and Respiratory Medicine

1. P. Ridker

Citations in the corpus

• A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease (2009, background): “Among such patients, a strong association between elevated troponin levels and recurrent coronary ischemic events has been firmly established.(2,3,4)”
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2002, background): “showed that pronounced elevation of troponin is associated with high long-term mortality, reduced left ventricular function but a modest risk of reinfarction([86]).”